1. Developing Targeted Potassium Channel Openers for CNS-Related Therapeutics

    Doug Krafte, Ph.D., Chief Scientific Officer, Neil Castle, Ph.D.
    Vice President of Research and Aaron Gerlach, Ph.D., Director of Business Development at Icagen explain the challenges and advances in the application of targeted potassium channel openers.

  2. Moving Quality to the Forefront Brings Measurable Results

    Chris Curtin, Executive Vice President and Chief Operating Officer of UPM Pharmaceuticals explains the implementation of Manufacturing Quality Assurance (MQA).

  3. With Respect to Supplier-Partner Relationships, What is Your Preferred Collaboration Model?
    Experts weigh in on our Roundtable question. 
  4. From Qualified to Ideal: The Importance of Partnership
    Nice Insight's virtual panelists weigh in on what makes contract service relationships work best.
  5. What is Your Perception of the State of Serialization in Your Sector of the Pharma Industry?

    Experts weigh in on our Roundtable question. 

  6. Investing for Successful Advancement of Viral Vector Manufacturing
    Mark Bamforth, CEO and Cofounder and Richard Synder, CSO at Brammer Bio, explain their approach to the latest in gene therapy.
  7. Mallinckrodt Completes Acquisition Of Sucampo Pharmaceuticals, Inc.

    Mallinckrodt has closed the acquisition of Sucampo Pharmaceuticals, Inc., a global biopharmaceutical company, including its commercial and development assets.

  8. Sirenas Enters Into Multi-Target Collaboration With Bristol-Myers Squibb

    Bristol-Myers Squibb will apply Sirenas' proprietary drug discovery technology, ATLANTIS, to multiple challenging therapeutic targets.

  9. Lonza Expands Cell-Culture Portfolio with Quasi Vivo System
    Lonza has announced the latest addition to its cell-culture product portfolio — the Quasi Vivo® System
  10. BioLife Solutions Executes OEM Agreement with MilliporeSigma

    BioLife Solutions has executed an OEM agreement to supply its CryoStor cell freeze media and HypoThermosol cell storage and shipping media under private label to MilliporeSigma.

  11. Transient Transfection at a Large Scale for Flexibility in Clinical and Commercial Vector Manufacturing

    Richard Snyder, Ph.D., Chief Scientific Officer, Scott Jeffers, Ph.D., Associate Director of Technical Operations and Ying Cai, Ph.D., Associate Director of Manufacturing Sciences at Brammer Bio discuss transient transfection for vector production.

  12. Behind the Scenes of International Pharmaceutical Business Success: A Conversation with Horst Wallrabe

    Haig Armaghanian is in conversation with Horst Wallrabe, formerly of Bayer, to reflect on his impressive career and what lies ahead.

  13. Flexible Partnership, Inflexible Quality
    Driven by the demand for biologics, most of which still require parenteral administration, the sterile injectable market is projected to continue its 6% annual growth through 2020.
  14. Equipment Redeployment’s Strategic Role

    Adam Covitt , Vice President of Federal Equipment Company, explains how to add flexibility and extend asset utilization. 

  15. Quality by Design: Transforming 21st Century Pharmaceutical Manufacturing

    John Moscariello, Ph.D., Vice President, Process Development at CMC Biologics discusses the QbD concept. 

  16. Looking forward, what technologies do you anticipate having the greatest impact in 2018?

    Experts weigh in on our Roundtable question.

  17. Fueled by Growth, Alcami Unveils New Sales Office in Cambridge, MA

    Alcami Corporation, a provider of custom end-to-end development and manufacturing services has announced the opening of a new sales office in the heart of Cambridge, Massachusetts.

  18. ImmunoQure AG and Servier Enter into Strategic Partnership for the Development of an Interferon-alpha Human Autoantibody

    The companies announced their exclusive partnership for the development of a therapeutic autoantibody neutralizing interferon-alpha.

  19. Label Update Approved for Novartis’ Cosentyx

    The FDA has approved a label update for the plaque psoriasis treatment.

  20. The Path Toward Generics: 2017’s Record-Breaking Year

    Generic approvals totaled 1,027 last year.

Nice Insight Research
Annual Study
A study of 163 CDMOs for use by both buyers and sellers of contract services with customer ratings
702 Respondents
313 Profiles
163 Deepdive
View Directory
Annual Study
Compare ratings for 73 CROs and clinical services providers to match buyer or seller needs
609 Respondents
124 Profiles
73 Deepdive
View Directory
Annual Study
Learn customer needs directly from 541 respondents to ensure you meet them and gain sales
541 Respondents
39 Profiles
31 Deepdive
View Directory
Annual Study
Find out the most important factors in equipment purchasing from 597 customers for the year for (bio)processing
597 Respondents
137 Profiles
90 Deepdive
View Directory
Clinical Supply
Chain Annual Study
320 customers rate key factors in supporting an emerging global clinical supply chain model
320 Respondents
22 Profiles
22 Deepdive
View Directory
Annual Study
545 buyers reveal key factors in sourcing and purchasing pharmaceutical intermediates
545 Respondents
86 Profiles
62 Deepdive
View Directory
Pharma's Almanac TV
View All Video

Road To BIO: Coming Soon To Your Screen

That’s Nice is producing a film based on the Road To BIO, for release in 2017. Watch the teaser trailer to get a taster of all the behind-the-scenes stories, character insights, and what went into the project.

Facility Expansion at Abzena

John Manzello, President, US, Abzena

Attracting Investors and Shortening Development Times

James C. Greenwood, President & CEO, Biotechnology Innovation Organization (BIO)

Providing a Complete Modular Solution

George Wiker, Executive Director, AES

Bringing Bioscience to Space

Bill Goodman, Ph.D., Vice President, SCORPIO-V, a Division of HNu Photonics
Devin Ridgley, Project Scientist, SCORPIO-V, a Division of HNu Photonics


The Path Toward Generics: 2017’s Record-Breaking Year

Feb 14, 2018 3:00:00 PM PAO-M02-18-NI-015

Label Update Approved for Novartis’ Cosentyx

Feb 14, 2018 3:00:00 PM PAO-M02-18-NI-014

China Invests Heavily in Western Biotech

Feb 13, 2018 2:57:41 PM PAO-M02-18-NI-013

Allergen Acquires Elastagen

Feb 13, 2018 2:54:04 PM PAO-M02-18-NI-012
Clinical Trials

Tyzivumab is Ready for Trials

Feb 9, 2018 10:18:38 AM PAO-M02-18-NI-011

Amgen to Open Biomanufacturing Plant in the US

Feb 9, 2018 10:15:34 AM PAO-M02-18-NI-010

Celanese Completes Omni Acquisition

Feb 8, 2018 10:58:23 AM PAO-M02-18-NI-009

Polpharma Group Gets Digital

Feb 8, 2018 10:49:56 AM PAO-M02-18-NI-008

Virtual Panel

ADCs: The Future of Biologic Drugs
The contract manufacturing market for antibody-drug conjugates has huge potential, but an extraordinary range of capabilities is essential to be in the game. We spoke to some of the players to find out all about ADCs.


Innovative Technologies

Design Logic

Marken: Stronger Than Ever
Now stronger than ever, Marken needed a bold visual direction to illustrate its expanding breadth of services and ongoing commitment to personalized medicine.
//Fix for text overflow in cards